United States: Bills Reintroduced In Congress After FDA Signals Potential New Regulatory Pathway For Cannabidiol Products - Foley Hoag LLP
On the heels of a January 2023 statement released by the FDA expressing the need for a new regulatory pathway for cannabidiol products, two CBD-related bills were reintroduced...
Full Article